Sharma, V., V. Bagrodia, and A. Kulshreshtra. “Enhancing Hemophilia A Management: Emicizumab As a Cost-Effective Adjunct to Standard Therapy for Inhibitor Patients”. International Journal of Basic & Clinical Pharmacology, vol. 13, no. 3, Apr. 2024, pp. 395-7, doi:10.18203/2319-2003.ijbcp20241000.